www.prnewswire.com
Open in
urlscan Pro
2606:4700:4400::ac40:9a3d
Public Scan
Submitted URL: https://go.spectramedix.com/e3t/Ctc/DK+113/cwG2z04/VW2vf-22Y2ZVW3TbjVW776Dd3V1-ywc4GMKm4N2L_pym5kh3GV3Zsc37CgTFZW38s-p08pmlz...
Effective URL: https://www.prnewswire.com/news-releases/megadeals-are-here-to-stay-and-theyre-redefining-the-healthcare-landscape-30150296...
Submission: On June 06 via api from US — Scanned from DE
Effective URL: https://www.prnewswire.com/news-releases/megadeals-are-here-to-stay-and-theyre-redefining-the-healthcare-landscape-30150296...
Submission: On June 06 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
<form class="search-bar">
<div class="input-group">
<input type="hidden" id="sitesearchurl" name="searchlink" value="/search/all/">
<input type="hidden" id="prodsearchurl" name="prodsearchlink" value="/search/products/">
<input type="hidden" id="resourcesearchurl" name="resourcesearchlink" value="/search/resources/">
<input type="hidden" id="orgsearchurl" name="orgsearchlink" value="/search/organization/">
<input type="hidden" id="allnewssearchurl" name="allnewssearchlink" value="/search/news/">
<input type="hidden" id="enableQuickSearch" name="enableQuickSearch" value="true">
<input type="hidden" id="newsVanityPathURL" name="newsVanityPathURL" value="/news/">
<label class="search-label" id="Search">Search</label>
<span class="sr-only" id="autopoplabel">When typing in this field, a list of search results will appear and be automatically updated as you type.</span>
<input type="text" id="sitesearchbox" name="Search" aria-describedby="autopoplabel" autocomplete="off" class="form-control form-search" placeholder="Search News Releases, Organizations, Resources, and Products"
aria-label="Search News Releases, Organizations, Resources, and Products">
</div>
<div class="qs-error">
</div>
</form>Text Content
Close menu
NewsProductsContact
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* 3 News in Focus
* 5 Business & Money
* 5 Science & Tech
* 5 Lifestyle & Health
* 0 Policy & Public Interest
* 1 People & Culture
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* All Products
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
Close submenu (News in Focus)News in Focus
* Browse All News
* Multimedia Gallery
* Trending Topics
Close submenu (Business & Money)Business & Money
* Auto & Transportation
* Business Technology
* Entertainment & Media
* Financial Services & Investing
* General Business
Close submenu (Science & Tech)Science & Tech
* Consumer Technology
* Energy & Natural Resources
* Environment
* Heavy Industry & Manufacturing
* Telecommunications
Close submenu (Lifestyle & Health)Lifestyle & Health
* Consumer Products & Retail
* Entertainment & Media
* Health
* Sports
* Travel
Close submenu (Policy & Public Interest)Policy & Public Interest
Close submenu (People & Culture)People & Culture
* People & Culture
* Resources
* Blog
* Journalists
* Log In
* Sign Up
* Data Privacy
* Send a Release
* News
* Products
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* Sponsored Placement
* All Products
* Contact
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
Search
Search When typing in this field, a list of search results will appear and be
automatically updated as you type.
Searching for your content...
No results found. Please change your search terms and try again.
* News in Focus
* * BROWSE NEWS RELEASES
* All News Releases
* All Public Company
* English-only
* NEWS RELEASES OVERVIEW
* MULTIMEDIA GALLERY
* All Multimedia
* All Photos
* All Videos
* MULTIMEDIA GALLERY OVERVIEW
* TRENDING TOPICS
* All Trending Topics
* Business & Money
* * AUTO & TRANSPORTATION
* All Automotive & Transportation
* Aerospace, Defense
* Air Freight
* Airlines & Aviation
* Automotive
* Maritime & Shipbuilding
* Railroads and Intermodal Transportation
* Supply Chain/Logistics
* Transportation, Trucking & Railroad
* Travel
* Trucking and Road Transportation
* AUTO & TRANSPORTATION OVERVIEW
* VIEW ALL AUTO & TRANSPORTATION
* BUSINESS TECHNOLOGY
* All Business Technology
* Blockchain
* Broadcast Tech
* Computer & Electronics
* Computer Hardware
* Computer Software
* Data Analytics
* Electronic Commerce
* Electronic Components
* Electronic Design Automation
* Financial Technology
* High Tech Security
* Internet Technology
* Nanotechnology
* Networks
* Peripherals
* Semiconductors
* BUSINESS TECHNOLOGY OVERVIEW
* VIEW ALL BUSINESS TECHNOLOGY
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* FINANCIAL SERVICES & INVESTING
* All Financial Services & Investing
* Accounting News & Issues
* Acquisitions, Mergers and Takeovers
* Banking & Financial Services
* Bankruptcy
* Bond & Stock Ratings
* Conference Call Announcements
* Contracts
* Cryptocurrency
* Dividends
* Earnings
* Earnings Forecasts & Projections
* Financing Agreements
* Insurance
* Investments Opinions
* Joint Ventures
* Mutual Funds
* Private Placement
* Real Estate
* Restructuring & Recapitalization
* Sales Reports
* Shareholder Activism
* Shareholder Meetings
* Stock Offering
* Stock Split
* Venture Capital
* FINANCIAL SERVICES & INVESTING OVERVIEW
* VIEW ALL FINANCIAL SERVICES & INVESTING
* GENERAL BUSINESS
* All General Business
* Awards
* Commercial Real Estate
* Corporate Expansion
* Earnings
* Environmental, Social and Governance (ESG)
* Human Resource & Workforce Management
* Licensing
* New Products & Services
* Obituaries
* Outsourcing Businesses
* Overseas Real Estate (non-US)
* Personnel Announcements
* Real Estate Transactions
* Residential Real Estate
* Small Business Services
* Socially Responsible Investing
* Surveys, Polls and Research
* Trade Show News
* GENERAL BUSINESS OVERVIEW
* VIEW ALL GENERAL BUSINESS
* Science & Tech
* * CONSUMER TECHNOLOGY
* All Consumer Technology
* Artificial Intelligence
* Blockchain
* Cloud Computing/Internet of Things
* Computer Electronics
* Computer Hardware
* Computer Software
* Consumer Electronics
* Cryptocurrency
* Data Analytics
* Electronic Commerce
* Electronic Gaming
* Financial Technology
* Mobile Entertainment
* Multimedia & Internet
* Peripherals
* Social Media
* STEM (Science, Tech, Engineering, Math)
* Supply Chain/Logistics
* Wireless Communications
* CONSUMER TECHNOLOGY OVERVIEW
* VIEW ALL CONSUMER TECHNOLOGY
* ENERGY & NATURAL RESOURCES
* All Energy
* Alternative Energies
* Chemical
* Electrical Utilities
* Gas
* General Manufacturing
* Mining
* Mining & Metals
* Oil & Energy
* Oil and Gas Discoveries
* Utilities
* Water Utilities
* ENERGY & NATURAL RESOURCES OVERVIEW
* VIEW ALL ENERGY & NATURAL RESOURCES
* ENVIRONMENT
* All Environment
* Conservation & Recycling
* Environmental Issues
* Environmental Policy
* Environmental Products & Services
* Green Technology
* Natural Disasters
* ENVIRONMENT OVERVIEW
* VIEW ALL ENVIRONMENT
* HEAVY INDUSTRY & MANUFACTURING
* All Heavy Industry & Manufacturing
* Aerospace & Defense
* Agriculture
* Chemical
* Construction & Building
* General Manufacturing
* HVAC (Heating, Ventilation and Air-Conditioning)
* Machinery
* Machine Tools, Metalworking and Metallurgy
* Mining
* Mining & Metals
* Paper, Forest Products & Containers
* Precious Metals
* Textiles
* Tobacco
* HEAVY INDUSTRY & MANUFACTURING OVERVIEW
* VIEW ALL HEAVY INDUSTRY & MANUFACTURING
* TELECOMMUNICATIONS
* All Telecommunications
* Carriers and Services
* Mobile Entertainment
* Networks
* Peripherals
* Telecommunications Equipment
* Telecommunications Industry
* VoIP (Voice over Internet Protocol)
* Wireless Communications
* TELECOMMUNICATIONS OVERVIEW
* VIEW ALL TELECOMMUNICATIONS
* Lifestyle & Health
* * CONSUMER PRODUCTS & RETAIL
* All Consumer Products & Retail
* Animals & Pets
* Beers, Wines and Spirits
* Beverages
* Bridal Services
* Cannabis
* Cosmetics and Personal Care
* Fashion
* Food & Beverages
* Furniture and Furnishings
* Home Improvement
* Household, Consumer & Cosmetics
* Household Products
* Jewelry
* Non-Alcoholic Beverages
* Office Products
* Organic Food
* Product Recalls
* Restaurants
* Retail
* Supermarkets
* Toys
* CONSUMER PRODUCTS & RETAIL OVERVIEW
* VIEW ALL CONSUMER PRODUCTS & RETAIL
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* HEALTH
* All Health
* Biometrics
* Biotechnology
* Clinical Trials & Medical Discoveries
* Dentistry
* FDA Approval
* Fitness/Wellness
* Health Care & Hospitals
* Health Insurance
* Infection Control
* International Medical Approval
* Medical Equipment
* Medical Pharmaceuticals
* Mental Health
* Pharmaceuticals
* Supplementary Medicine
* HEALTH OVERVIEW
* VIEW ALL HEALTH
* SPORTS
* All Sports
* General Sports
* Outdoors, Camping & Hiking
* Sporting Events
* Sports Equipment & Accessories
* SPORTS OVERVIEW
* VIEW ALL SPORTS
* TRAVEL
* All Travel
* Amusement Parks and Tourist Attractions
* Gambling & Casinos
* Hotels and Resorts
* Leisure & Tourism
* Outdoors, Camping & Hiking
* Passenger Aviation
* Travel Industry
* TRAVEL OVERVIEW
* VIEW ALL TRAVEL
* Policy & Public Interest
* * POLICY & PUBLIC INTEREST
* All Policy & Public Interest
* Advocacy Group Opinion
* Animal Welfare
* Congressional & Presidential Campaigns
* Corporate Social Responsibility
* Domestic Policy
* Economic News, Trends, Analysis
* Education
* Environmental
* European Government
* FDA Approval
* Federal and State Legislation
* Federal Executive Branch & Agency
* Foreign Policy & International Affairs
* Homeland Security
* Labor & Union
* Legal Issues
* Natural Disasters
* Not For Profit
* Patent Law
* Public Safety
* Trade Policy
* U.S. State Policy
* POLICY & PUBLIC INTEREST OVERVIEW
* VIEW ALL POLICY & PUBLIC INTEREST
* People & Culture
* * PEOPLE & CULTURE
* All People & Culture
* Aboriginal, First Nations & Native American
* African American
* Asian American
* Children
* Diversity, Equity & Inclusion
* Hispanic
* Lesbian, Gay & Bisexual
* Men's Interest
* People with Disabilities
* Religion
* Senior Citizens
* Veterans
* Women
* PEOPLE & CULTURE OVERVIEW
* VIEW ALL PEOPLE & CULTURE
* In-Language News
* español
* português
* Česko
* Danmark
* Deutschland
* España
* France
* Italia
* Nederland
* Norge
* Polska
* Portugal
* Россия
* Slovensko
* Suomi
* Sverige
* Overview
* Distribution by PR Newswire
* Cision Communications Cloud®
* Cision IR
* Sponsored Placement
* All Products
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
*
*
* Send a Release
*
* * ALL CONTACT INFO
* Contact Us
888-776-0942
from 8 AM - 10 PM ET
*
* *
MEGADEALS ARE HERE TO STAY, AND THEY'RE REDEFINING THE HEALTHCARE LANDSCAPE
--------------------------------------------------------------------------------
News provided by
Bain & Company
Mar 15, 2022, 09:23 ET
SHARE THIS ARTICLE
Share this article
--------------------------------------------------------------------------------
Bain & Company's 11th annual Global Healthcare Private Equity and M&A Report
shows the resilience of the healthcare industry, with $151 billion in capital
surging into healthcare globally in 2021
BOSTON, March 15, 2022 /PRNewswire/ -- 2021 was a record-breaking year for
healthcare investors, bouncing back from the pandemic-induced lull of 2020.
Despite the ongoing impacts of Covid-19, however, healthcare private equity saw
record-levels of deal volume and disclosed value, with $151 billion in capital
surging into healthcare globally and deal volume rising by 36%.
Bain & Company's 11th annual Global Healthcare Private Equity and M&A Report,
released today, highlights the most important takeaway of healthcare private
equity over the last year: the exponential rise in megadeals—deals valued at
more than $1 billion.
In 2021, large healthcare private equity deals returned in force, with a record
30 transactions valued at greater than $1 billion. These deals caused disclosed
value to more than triple to $122 billion from $38 billion the prior year.
Notably, there was also an increase in deals north of $15 billion. With
healthcare returns expected to remain strong, the continued growth in valuations
will likely lead to a steady stream of large deals. The consortium, or bidders
that were able to partner and pool capital together, will remain an important
presence in this space, particularly for transactions above $5 billion.
Additionally, as the region continued its multiyear growth trajectory,
Asia-Pacific markets are seeing increased consumerism and willingness to spend
in healthcare, which has fueled activity, especially with investments in
building a more robust consumer-centric digital health environment.
"The ongoing impacts of the Covid-19 pandemic continue to stress the supply
chain, wrench forward the progress of digital care and stretch many sectors thin
with labor shortages," said Nirad Jain, co-lead of Healthcare Private Equity at
Bain & Company. "But the pandemic has also highlighted many new opportunities in
the healthcare industry, encouraging innovation in segments, such as mental
health treatments and at-home care. These developments will continue to entice
more diverse investors to pursue opportunities in the healthcare sectors."
Apart from the pandemic, other structural changes are washing through healthcare
systems globally that give reason for optimism. One positive shift is that
technological innovations—including digital tools that redefine how patients
interact with care, the use of artificial intelligence in drug discovery and
software that enables value-based care—are helping companies build new business
models. Due to these developments, the near- to medium-term future may see more
healthcare assets going and staying private.
Biopharma: building strong innovation pipelines
In contrast to the market uncertainties of 2020, strong fundamentals in
biopharmaceuticals produced a number of large deals in 2021, especially in
Europe. Disclosed deal value surged to $33 billion, up from $20 billion the year
prior. Corporate M&A activity also blossomed as buyers sought to enhance drug
development capabilities and become more efficient.
Other factors should work in the industry's favor in the years ahead: aging
populations in high-income countries will increase demand for therapeutics; and
abundant government, university and private funding for R&D has built strong
innovation pipelines across therapeutic modalities and disease states.
Providers: managing a tightening labor market
Healthcare providers were forced to adapt to a changing industry in 2021. New
care models and supporting businesses fueled a record year for provider deals,
with disclosed deal value reaching $51.3 billion, well above the previous high
of $35.8 billion.
However, healthcare workers are leaving their jobs at higher rates as the
pandemic continues to take a toll on their mental and physical health. This
places an increasing pressure on provider organizations, with many facing higher
labor costs and an inability to meet patient demand. Companies that helped fill
these vacancies attracted new attention from investors in 2021.
Retail health was another key theme in 2021. The pandemic accelerated growth
within the pet industry, fueling a surge in deal activity for veterinary care
assets last year. The pandemic also increased demand for and strengthened
employer commitment to mental health services. In the US and Europe, investors
bought several brick-and-mortar mental health companies last year. And dental
practices remain a hot category for investment, with specialty dental proving to
be fragmented category ripe for consolidation.
Payers: addressing the social determinants of health
With costs rising rapidly and value-based care models maturing, the role of US
payers is being redefined, leading to major opportunities for value creation.
Disclosed deal value for payer buyouts rose to $15.3 billion in 2021, up from
$4.4 billion in 2020. Given the diverse and largely private payer landscape in
the US, the deal activity was concentrated in North America.
The pandemic exposed the profound effects of social circumstances on health
outcomes, and as payers take on more responsibility for these outcomes, they
will look for partners to address what influences health outside of the
traditional purview of medicine. Thus, firms that help payers address the social
determinants of health will attract more investment, and valuations will rise
for companies that reduce costs and improve the member experience.
Medtech: strengthening supply chains
Investors completed 96 medtech deals in 2021, a sharp increase from 55 deals in
2020. Four of these transactions were also valued at $1 billion or more—the
highest megadeal count to date in this sector. Deal value for medtech buyouts
also surged to $40.8 billion from $3 billion in 2020, largely reflecting the $34
billion deal for Medline.
Amid ongoing supply chain frustrations, healthcare companies have sought
providers that can reliably and cost-effectively supply essential tools and
equipment. They are also prioritizing cost cutting related to equipment
maintenance, repair and refurbishment, spurring deals of providers in this area.
Outside of physical infrastructure, private equity has been attracted to digital
supply chains and distribution infrastructure for providers. As providers and
payers continue to reinvent care delivery, medtech companies also play a large
role in supporting a shift to home-based care.
"Investors, who currently possess record amounts of available capital, have been
increasingly attracted to the healthcare market, citing the industry's
resilience, high returns, clear opportunities for innovation and ESG impact"
said Kara Murphy, co-lead of Healthcare Private Equity at Bain & Company.
"Investors that come out ahead will be keeping an eye on potential
public-to-private transactions, the transformative role of technology, the
momentum behind value-based care and global dynamics including the
Russia-Ukraine war."
Editor's Note: To arrange an interview, contact Katie Ware at
katie.ware@bain.com or +1 646 562 8107.
About Bain & Company
Bain & Company is a global consultancy that helps the world's most ambitious
change makers define the future.
Across 63 offices in 38 countries, we work alongside our clients as one team
with a shared ambition to achieve extraordinary results, outperform the
competition, and redefine industries. We complement our tailored, integrated
expertise with a vibrant ecosystem of digital innovators to deliver better,
faster, and more enduring outcomes. Our 10-year commitment to invest more than
$1 billion in pro bono services brings our talent, expertise, and insight to
organizations tackling today's urgent challenges in education, racial equity,
social justice, economic development, and the environment. We earned a gold
rating from EcoVadis, the leading platform for environmental, social, and
ethical performance ratings for global supply chains, putting us in the top 2%
of all companies. Since our founding in 1973, we have measured our success by
the success of our clients, and we proudly maintain the highest level of client
advocacy in the industry.
SOURCE Bain & Company
×
MODAL TITLE
ALSO FROM THIS SOURCE
MOVING BEYOND "WELCOMING EVERYONE" TO CREATING TRULY INCLUSIVE...
--------------------------------------------------------------------------------
BAIN & COMPANY JOINS FORCES WITH JUPITER TO BRING CLIMATE...
EXPLORE
More news releases in similar topics
* Computer & Electronics
* Banking & Financial Services
* Data Analytics
* Health Care & Hospitals
* Surveys, Polls and Research
CONTACT CISION
* Cision Distribution 888-776-0942
from 8 AM - 9 PM ET
* Chat with an Expert
Contact Us
* General Inquiries
* Request a Demo
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
PRODUCTS
* Cision Communication Cloud®
* For Marketers
* For Public Relations
* For IR & Compliance
* For Agency
* For Small Business
* All Products
ABOUT
* About PR Newswire
* About Cision
* Become a Publishing Partner
* Become a Channel Partner
* Careers
* COVID-19 Resources
* Accessibility Statement
Global Sites
* Asia
* Brazil
* Canada
* Czech
* Denmark
* Finland
* France
* Germany
* India
* Israel
* Italy
* Mexico
* Middle East
* Netherlands
* Norway
* Poland
* Portugal
* Russia
* Slovakia
* Spain
* Sweden
* United Kingdom
MY SERVICES
* All New Releases
* Online Member Center
* ProfNet
CONTACT CISION
PRODUCTS
ABOUT
My Services
* All News Releases
* Online Member Center
* ProfNet
Cision Distribution Helpline
888-776-0942
* Terms of Use
* Privacy Policy
* Information Security Policy
* Site Map
* RSS
* Cookie Settings
Copyright © 2022 Cision US Inc.
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. More information
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY
Always Active
These technologies are needed to enable our websiteto run and keep it secure.
PERFORMANCE ANALYTICS
Performance Analytics
These technologies tell us how you use our sites and apps, and provide
information to help us improve the website and browser experience.
FUNCTIONAL
Functional
These technologies allow us to provide enhanced functionality and personalise
content for you. For example they're used to recognise you when you return to
our website. If you do not allow these technologies then some or all these
services may not function properly.
MARKETING
Marketing
These services helps us decide which products, services and content may be
relevant for you. We use this data to customise the content you see on our
websites and social media. These technologies are set by us or by our
carefully-selected third parties. They help us understand the performance of our
marketing activities and improve the relevance of the content that you see.
BACK BUTTON PERFORMANCE COOKIES
Vendor Search Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Reject All Confirm My Choices
By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts.
Reject All Accept All Cookies
Cookies Settings